Indofood Cbp Sukses Makmur Tbk (ICBP)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 5,975.00 |
|---|---|
| 52-week range | 5,500.00 – 8,975.00 |
| Return, 1 month / 3 months | −13.1% / −16.1% |
| Return, 1 year / 3 years | −29.6% / −38.2% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 31.0% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 40,331.58M IDR |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Indofood CBP Sukses Makmur is an Indonesian packaged food company based in Jakarta. It makes instant noodles, dairy products, snack foods, food seasonings and beverages, and its products are sold to households and consumers through retail shops and distributors in Indonesia and in export markets. Its brands include Indomie instant noodles and other packaged food lines that form part of everyday cooking and eating for many families across the region.
On this site Indofood Cbp Sukses Makmur Tbk appears as a stock on the Jakarta Exchange (Indonesia), code ICBP, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Indofood Cbp Sukses Makmur Tbk (ICBP) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 5,975.00 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 238 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.6% and over the last three months it fell 16.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.9% | ||
| From 52-week high | -32.5% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.1% | ||
| 6-month return | -12.2% | ||
| 12-month return, skipping the last month | -19.0% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 40,331.58M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −13.1% |
| 3 months | −16.1% |
| 6 months | −12.2% |
| 1 year | −29.6% |
| 3 years | −38.2% |
| 5 years | −25.7% |
Signals
| 50-day / 200-day average | 7,016.00 / 7,023.20 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 252.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | IDR 265.0000 |
| 2 Jul 2025 | IDR 250.0000 |
| 9 Jul 2024 | IDR 200.0000 |
| 7 Jul 2023 | IDR 188.0000 |
| 2 Aug 2022 | IDR 215.0000 |
| 7 Sep 2021 | IDR 215.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.